Watchlist Price Alert

China Traditional Chinese... (CHIZF)

PNK: CHIZF · Real-Time Price · USD

0.34

0.00 (1.19%)

At close: May 01, 2025, 8:00 PM

China Traditional Chinese Medicine Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	8.39B	8.82B	9.3B	8.39B	5.91B	10.9B	8.15B	8.15B	6.66B	7.38B	6.94B	5.8B	5.46B	4.44B	3.9B	3.33B	3.2B
Cost of Revenue	4.32B	4.3B	4.54B	4.15B	2.96B	4.08B	3.15B	3.04B	2.64B	3B	2.75B	2.53B	2.53B	1.96B	1.73B	1.38B	1.37B
Gross Profit	4.06B	4.52B	4.76B	4.25B	2.95B	6.83B	5B	5.11B	4.02B	4.39B	4.19B	3.26B	2.93B	2.48B	2.17B	1.95B	1.83B
Operating Income	384.58M	613.23M	783.29M	634.51M	540.45M	1.41B	1.3B	1.39B	1.09B	1.2B	1.23B	1.01B	1.09B	878.76M	882.61M	603.27M	681.78M
Interest Income	n/a	59.65M	74.14M	81.86M	71.57M	73.88M	85.58M	106.22M	90.84M	163.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	299.43M	517.72M	706.81M	370.34M	469.77M	1.32B	1.2B	1.24B	990.37M	1.01B	1.14B	853.82M	1B	768M	799.24M	638.46M	665.35M
Net Income	210.98M	706.46M	578.74M	350.9M	413.59M	1B	929.83M	931.24M	732.02M	728.99M	859.12M	678.71M	760.31M	571.81M	598.62M	476.15M	490.78M
Selling & General & Admin	3.42B	3.76B	3.7B	3.4B	2.16B	5.11B	3.47B	3.53B	2.81B	3B	2.81B	2.16B	1.71B	1.58B	1.19B	1.23B	1.06B
Research & Development	267.93M	372.02M	313.61M	294.3M	317.53M	399.74M	294.7M	305.15M	245.32M	255M	209M	197.45M	149.09M	80.56M	121.6M	86.8M	100.03M
Other Expenses	-12.88M	-226.95M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-31.43M	-31.43M	-33.45M
Operating Expenses	3.68B	3.9B	3.98B	3.79B	2.41B	5.43B	3.72B	3.76B	2.94B	3.21B	2.96B	2.26B	1.82B	1.6B	1.3B	1.28B	1.15B
Interest Expense	n/a	n/a	238.49M	274.08M	n/a	n/a	n/a	n/a	n/a	n/a	150.52M	150.52M	146.15M	146.15M	110.53M	110.53M	36.71M
Selling & Marketing Expenses	2.75B	3.22B	3.19B	2.89B	1.72B	4.54B	3.04B	3.14B	2.44B	2.66B	2.45B	1.93B	1.49B	1.41B	1.02B	1.09B	876.91M
Cost & Expenses	8B	8.21B	8.52B	7.94B	5.37B	9.51B	6.87B	6.8B	5.57B	6.21B	5.71B	4.8B	4.36B	3.56B	3.03B	2.66B	2.51B
Income Tax Expense	85.29M	261.39M	89.85M	70.91M	48.23M	205.61M	191.24M	209.27M	160.17M	195.3M	186.03M	121.25M	168.42M	119.33M	136.47M	97M	120.27M
Shares Outstanding (Basic)	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	4.61B	4.43B	4.43B	4.43B	4.47B
Shares Outstanding (Diluted)	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	4.61B	4.43B	4.43B	4.43B	4.47B
EPS (Basic)	0.04	0.14	0.12	0.07	0.08	0.20	0.18	0.18	0.15	0.14	0.17	0.13	0.17	0.13	0.14	0.11	0.11
EPS (Diluted)	0.04	0.14	0.12	0.07	0.08	0.20	0.18	0.18	0.15	0.14	0.17	0.13	0.17	0.13	0.14	0.11	0.11
EBITDA	907.73M	1.09B	1.33B	1.16B	1.06B	1.84B	1.67B	1.73B	1.39B	1.47B	1.51B	1.28B	1.33B	1.1B	1.06B	766.12M	845.13M
EBIT	371.05M	565.38M	785.24M	634.51M	540.45M	1.41B	1.3B	1.39B	1.09B	1.2B	1.23B	1.01B	1.09B	878.76M	882.61M	603.27M	681.78M
Depreciation & Amortization	536.68M	528.35M	544.03M	521.74M	519.57M	428.78M	366.95M	340.1M	301.03M	271.94M	275.72M	265.28M	240.35M	225.06M	177.25M	162.85M	163.35M